**Core Concept**
The management of smoking cessation involves pharmacological interventions that target the nicotinic acetylcholine receptor (nAChR) in the brain, aiming to reduce cravings and withdrawal symptoms associated with nicotine addiction.

**Why the Correct Answer is Right**
The primary pharmacological interventions for smoking cessation include nicotine replacement therapy (NRT), non-nicotine prescription medications such as bupropion (Zyban), and varenicline (Chantix). NRT helps to manage withdrawal symptoms and cravings by providing a controlled release of nicotine, while bupropion and varenicline work by modulating the activity of the nAChR, thereby reducing the rewarding effects of nicotine. Varenicline, in particular, is a partial agonist at the α4β2 subtype of the nAChR, which is involved in the regulation of nicotine reward and reinforcement.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not specify a known pharmacological intervention for smoking cessation.
**Option B:** This option is incorrect as it is not a recognized medication for smoking cessation.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that combination therapy, involving both NRT and a non-nicotine prescription medication, can be more effective than monotherapy in promoting smoking cessation.

**Correct Answer: A. Nicotine replacement therapy (NRT)